Standing up in public for a broader conception of value in healthcare.

9-16 of 72 News

viewpoint 6/02/17

On the Health Affairs Blog: Light Addresses the Pharma "Free Rider Myth” (in Response To Yu, Helms, and Bach) Donald Light submits a response to Yu, Helms and Bach's recent Health Affairs blog post on the subject of drug pricing. Light argues that, because the commentary by Yu, Helms, and Bach focuses on the excess of US drug pricing over prices in other developed countries, the authors risk promoting the so-called "foreign free-rider myth," relying on a misperception that the US is paying more than their fare share of drug development costs. READ MORE

viewpoint 6/02/17

On the Health Affairs Blog: Grabowski and Manning Respond To A Recent Post by Yu, Helms, and Bach Henry Grabowski and Richard Manning offer a rebuttal to a recent Health Affairs blog post by authors Yu, Helms, and Bach on the subject of drug pricing, arguing the authors’ premise is flawed and suffers from numerous biases and related methodological issues. READ MORE

viewpoint 6/01/17

On the Health Affairs Blog: Carrier and Shadowen Propose Fixes for Pharma "Product Hopping" Michael Carrier and Steve Shadower present the issue of "product hopping," in which pharma manufacturers can delay the generic introduction of a drug through reformulation. In addition to examining the issue, Carrier and Shadowen propose some criteria for the development of a new framework to address abuses in this practice. READ MORE

viewpoint 5/26/17

On the Health Affairs Blog: Manolis, Good and Shrank Address Abuse-Deterrent Opioids Chronis Manolis, C Bernie Good and William Shrank discuss current approaches to curb opioid abuse, including the proposal to mandate coverage of abuse-deterrent opioids. READ MORE

viewpoint 5/23/17

On the Health Affairs Blog: What Matters Most To Patients Josh Seidman, Margaret Anderson, Domitilla Masi, Melea Atkins and Maureen Japha provide an overview of the Avalere-FasterCures Patient-Perspective Value Framework. READ MORE

event 5/23/17

Baumgardner Participates in Becker Friedman Institute's Health Care Reform Panel On May 22nd, James Baumgardner, who provides legislative policy expertise as a part of IVI's Scientific Advisory Group, was an invited panelist for a forum at The University of Chicago's Becker Friedman Institute. READ MORE

viewpoint 5/18/17

On the Health Affairs Blog: Seabury and Sood Examine Policies to Promote Development of Antimicrobial Drugs Seth Seabury and Neeraj Sood propose a new model for the development of antimicrobial drugs. Market entry awards, exclusivity extensions and priority review vouchers are all critical tools that the authors examine, weighing their strengths and weaknesses. READ MORE

event 5/18/17

IVI's Lakdawalla and Balch Participate in NPAF Consortium On May 17th, IVI's Executive Director Darius Lakdawalla and Panel of Health Advisors member Alan Balch spoke at the National Patient Advocate Foundation's (NPAF) Spring 2017 Policy Consortium. The event launched the NPAF "Roadmap to Consumer Clarity in Healthcare Decision Making.” Both NPAF and IVI are committed to providing patients with accessible and useful information about the value of their healthcare options. READ MORE